{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:25:58Z","timestamp":1787577958678,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,13]]},"DOI":"10.7759\/cureus.105181","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:27:13Z","timestamp":1773422833000},"source":"Crossref","is-referenced-by-count":1,"title":["PURA-Related Neurodevelopmental Disorder: A Comprehensive Clinical Review of Genetics, Phenotype, and Emerging Therapeutic Strategies"],"prefix":"10.7759","author":[{"given":"Sadaf","family":"Afshar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajiha","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif \u00d6zge","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumayyah S","family":"Younis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamuna Karthika Rao","family":"Potluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaskaran","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak Swaroop","family":"Meda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kopparti K","family":"Manjari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvin","family":"Khachikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayalekshmi","family":"Leena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2014-102798","article-title":"Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability","volume":"51","author":"Hunt D","year":"2014","unstructured":"Hunt D, Leventer RJ, Simons C, et al.. Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability. J Med Genet. 2014, 51:806-13. 10.1136\/jmedgenet-2014-102798","journal-title":"J Med Genet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2014.09.014","article-title":"Mutations in PURA cause profound neonatal hypotonia, seizures, and encephalopathy in 5q31.3 microdeletion syndrome","volume":"95","author":"Lalani SR","year":"2014","unstructured":"Lalani SR, Zhang J, Schaaf CP, et al.. Mutations in PURA cause profound neonatal hypotonia, seizures, and encephalopathy in 5q31.3 microdeletion syndrome. Am J Hum Genet. 2014, 95:579-83. 10.1016\/j.ajhg.2014.09.014","journal-title":"Am J Hum Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.17.3197","article-title":"Puralpha: a multifunctional single-stranded DNA- and RNA-binding protein","volume":"28","author":"Gallia GL","year":"2000","unstructured":"Gallia GL, Johnson EM, Khalili K. Puralpha: a multifunctional single-stranded DNA- and RNA-binding protein. Nucleic Acids Res. 2000, 28:3197-205. 10.1093\/nar\/28.17.3197","journal-title":"Nucleic Acids Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.638217","article-title":"The molecular function of PURA and its implications in neurological disease","volume":"12","author":"Molitor L","year":"2021","unstructured":"Molitor L, Bacher S, Burczyk S, Niessing D. The molecular function of PURA and its implications in neurological disease. Front Genet. 2021, 12:638217. 10.3389\/fgene.2021.638217","journal-title":"Front Genet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2017-104946","article-title":"PURA syndrome: clinical delineation and genotype-phenotype study in 32 individuals with review of published literature","volume":"55","author":"Reijnders MR","year":"2018","unstructured":"Reijnders MR, Janowski R, Alvi M, et al.. PURA syndrome: clinical delineation and genotype-phenotype study in 32 individuals with review of published literature. J Med Genet. 2018, 55:104-13. 10.1136\/jmedgenet-2017-104946","journal-title":"J Med Genet"},{"key":"ref6","unstructured":"PURA Foundation Australia. (2025). Accessed. September 5, 2025: https:\/\/www.purafoundation.au\/pura."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03908-9","article-title":"Genotype-phenotype variations in PURA syndrome: Asian and non-Asian perspectives from a systematic review","volume":"20","author":"Liu SN","year":"2025","unstructured":"Liu SN, Chi CS, Lee HF, Tsai CR, Yang YL, Wu PY. Genotype-phenotype variations in PURA syndrome: Asian and non-Asian perspectives from a systematic review. Orphanet J Rare Dis. 2025, 20:376. 10.1186\/s13023-025-03908-9","journal-title":"Orphanet J Rare Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2025.1607213","article-title":"PURA syndrome-a genetic cause of a neurodevelopmental disorder-case report","volume":"13","author":"Kobak J","year":"2025","unstructured":"Kobak J, Szczupak M, Czerkiewicz K, Bielocerkowski S, Krupa-Nurcek S. PURA syndrome-a genetic cause of a neurodevelopmental disorder-case report. Front Pediatr. 2025, 13:1607213. 10.3389\/fped.2025.1607213","journal-title":"Front Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000613","article-title":"PURA-related developmental and epileptic encephalopathy: phenotypic and genotypic spectrum","volume":"7","author":"Johannesen KM","year":"2021","unstructured":"Johannesen KM, Gardella E, Gjerulfsen CE, et al.. PURA-related developmental and epileptic encephalopathy: phenotypic and genotypic spectrum. Neurol Genet. 2021, 7:e613. 10.1212\/NXG.0000000000000613","journal-title":"Neurol Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.38521","article-title":"Expanding the neurodevelopmental phenotype of PURA syndrome","volume":"176","author":"Lee BH","year":"2018","unstructured":"Lee BH, Reijnders MR, Abubakare O, et al.. Expanding the neurodevelopmental phenotype of PURA syndrome. Am J Med Genet A. 2018, 176:56-67. 10.1002\/ajmg.a.38521","journal-title":"Am J Med Genet A"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000200181","article-title":"Inherited PURA pathogenic variant associated with a mild neurodevelopmental disorder","volume":"10","author":"Hildebrand MS","year":"2024","unstructured":"Hildebrand MS, Braden RO, Lauretta ML, et al.. Inherited PURA pathogenic variant associated with a mild neurodevelopmental disorder. Neurol Genet. 2024, 10:e200181. 10.1212\/NXG.0000000000200181","journal-title":"Neurol Genet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13741","article-title":"A genome-wide association study identifies FSHR rs2300441 associated with follicle-stimulating hormone levels","volume":"97","author":"Yan J","year":"2020","unstructured":"Yan J, Tian Y, Gao X, et al.. A genome-wide association study identifies FSHR rs2300441 associated with follicle-stimulating hormone levels. Clin Genet. 2020, 97:869-77. 10.1111\/cge.13741","journal-title":"Clin Genet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13272","article-title":"Complex movement disorders in a boy with PURA syndrome","volume":"8","author":"Lin SJ","year":"2021","unstructured":"Lin SJ, Lin YF, Tsai CH, Huang CH, Ho F, Tsai SF, Lin WS. Complex movement disorders in a boy with PURA syndrome. Mov Disord Clin Pract. 2021, 8:1137-9. 10.1002\/mdc3.13272","journal-title":"Mov Disord Clin Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.14507","article-title":"Strabismus in genetic syndromes: a review","volume":"53","author":"Kilic S","year":"2025","unstructured":"Kilic S, Bove J, So BN, Whitman MC. Strabismus in genetic syndromes: a review. Clin Exp Ophthalmol. 2025, 53:302-30. 10.1111\/ceo.14507","journal-title":"Clin Exp Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03083-3","article-title":"The spectrum of neurological presentation in individuals affected by TBL1XR1 gene defects","volume":"19","author":"Nagy A","year":"2024","unstructured":"Nagy A, Molay F, Hargadon S, et al.. The spectrum of neurological presentation in individuals affected by TBL1XR1 gene defects. Orphanet J Rare Dis. 2024, 19:79. 10.1186\/s13023-024-03083-3","journal-title":"Orphanet J Rare Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2024-110379","article-title":"PURA-related neurodevelopmental disorders: a systematic review on genotype-phenotype correlations","volume":"62","author":"Taniguchi N","year":"2025","unstructured":"Taniguchi N, Watanuki K, Nakato D, Takenouchi T, Kosaki K, Koga H. PURA-related neurodevelopmental disorders: a systematic review on genotype-phenotype correlations. J Med Genet. 2025, 62:191-8. 10.1136\/jmg-2024-110379","journal-title":"J Med Genet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101167","article-title":"Genome-wide epigenetic signatures facilitated the variant classification of the PURA gene and uncovered the pathomechanism of PURA-related neurodevelopmental disorders","volume":"26","author":"Xiao B","year":"2024","unstructured":"Xiao B, Dai W, Zhan Y, et al.. Genome-wide epigenetic signatures facilitated the variant classification of the PURA gene and uncovered the pathomechanism of PURA-related neurodevelopmental disorders. Genet Med. 2024, 26:101167. 10.1016\/j.gim.2024.101167","journal-title":"Genet Med"},{"key":"ref18","article-title":"PURA-related neurodevelopmental disorders","author":"Reijnders MR","year":"2017","unstructured":"Reijnders MR, Leventer RJ, Lee BH, et al.. PURA-related neurodevelopmental disorders. Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (ed): GeneReviews\u00ae [Internet], Seattle, WA; 2017."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/genes15070848","article-title":"PURA-related neurodevelopmental disorders with epilepsy treated with ketogenic diet: a case-based review","volume":"15","author":"Falsaperla R","year":"2024","unstructured":"Falsaperla R, Sortino V, Schinocca MA, et al.. PURA-related neurodevelopmental disorders with epilepsy treated with ketogenic diet: a case-based review. Genes (Basel). 2024, 15:848. 10.3390\/genes15070848","journal-title":"Genes (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70091","article-title":"Gene therapy for genetic diseases: challenges and future directions","volume":"6","author":"Qie B","year":"2025","unstructured":"Qie B, Tuo J, Chen F, Ding H, Lyu L. Gene therapy for genetic diseases: challenges and future directions. MedComm (2020). 2025, 6:e70091. 10.1002\/mco2.70091","journal-title":"MedComm (2020)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02238-2","article-title":"Multiomic analyses implicate a neurodevelopmental program in the pathogenesis of cerebral arachnoid cysts","volume":"29","author":"Kundishora AJ","year":"2023","unstructured":"Kundishora AJ, Allington G, McGee S, et al.. Multiomic analyses implicate a neurodevelopmental program in the pathogenesis of cerebral arachnoid cysts. Nat Med. 2023, 29:667-78. 10.1038\/s41591-023-02238-2","journal-title":"Nat Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01599-y","article-title":"Clinical and genetic characteristics and prenatal diagnosis of patients presented GDD\/ID with rare monogenic causes","volume":"15","author":"Lin L","year":"2020","unstructured":"Lin L, Zhang Y, Pan H, Wang J, Qi Y, Ma Y. Clinical and genetic characteristics and prenatal diagnosis of patients presented GDD\/ID with rare monogenic causes. Orphanet J Rare Dis. 2020, 15:317. 10.1186\/s13023-020-01599-y","journal-title":"Orphanet J Rare Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.21037\/tp-20-248","article-title":"Neonatal PURA syndrome: a case report and literature review","volume":"10","author":"Liu Y","year":"2021","unstructured":"Liu Y, Liu R, Xu T, Zhou YX, Zhang SC. Neonatal PURA syndrome: a case report and literature review. Transl Pediatr. 2021, 10:194-203. 10.21037\/tp-20-248","journal-title":"Transl Pediatr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01242-6","article-title":"Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Manickam K","year":"2021","unstructured":"Manickam K, McClain MR, Demmer LA, et al.. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021, 23:2029-37. 10.1038\/s41436-021-01242-6","journal-title":"Genet Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-68163-9","article-title":"Integrative transcriptome-wide association analyses reveal PRKCG-linked GABAergic dysfunction in fragile X-associated tremor\/ataxia syndrome","volume":"17","author":"Jin Y","year":"2026","unstructured":"Jin Y, Cao Y, Ma W, et al.. Integrative transcriptome-wide association analyses reveal PRKCG-linked GABAergic dysfunction in fragile X-associated tremor\/ataxia syndrome. Nat Commun. 2026, 17:1418. 10.1038\/s41467-025-68163-9","journal-title":"Nat Commun"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00063.2021","article-title":"Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum","volume":"103","author":"Guerrini R","year":"2023","unstructured":"Guerrini R, Conti V, Mantegazza M, Balestrini S, Galanopoulou AS, Benfenati F. Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum. Physiol Rev. 2023, 103:433-513. 10.1152\/physrev.00063.2021","journal-title":"Physiol Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaf059","article-title":"Combined genomics and proteomics unveils elusive variants and vast aetiologic heterogeneity in dystonia","volume":"148","author":"Zech M","year":"2025","unstructured":"Zech M, Dzinovic I, Skorvanek M, et al.. Combined genomics and proteomics unveils elusive variants and vast aetiologic heterogeneity in dystonia. Brain. 2025, 148:2827-46. 10.1093\/brain\/awaf059","journal-title":"Brain"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo7112","article-title":"De novo variants in genes regulating stress granule assembly associate with neurodevelopmental disorders","volume":"8","author":"Jia X","year":"2022","unstructured":"Jia X, Zhang S, Tan S, et al.. De novo variants in genes regulating stress granule assembly associate with neurodevelopmental disorders. Sci Adv. 2022, 8:eabo7112. 10.1126\/sciadv.abo7112","journal-title":"Sci Adv"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr476","article-title":"Lack of Pur-alpha alters postnatal brain development and causes megalencephaly","volume":"21","author":"Hokkanen S","year":"2012","unstructured":"Hokkanen S, Feldmann HM, Ding H, et al.. Lack of Pur-alpha alters postnatal brain development and causes megalencephaly. Hum Mol Genet. 2012, 21:473-84. 10.1093\/hmg\/ddr476","journal-title":"Hum Mol Genet"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.23.19.6857-6875.2003","article-title":"Puralpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse","volume":"23","author":"Khalili K","year":"2003","unstructured":"Khalili K, Del Valle L, Muralidharan V, et al.. Puralpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse. Mol Cell Biol. 2003, 23:6857-75. 10.1128\/MCB.23.19.6857-6875.2003","journal-title":"Mol Cell Biol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2016.09.018","article-title":"Memory deficits, gait ataxia and neuronal loss in the hippocampus and cerebellum in mice that are heterozygous for Pur-alpha","volume":"337","author":"Barbe MF","year":"2016","unstructured":"Barbe MF, Krueger JJ, Loomis R, Otte J, Gordon J. Memory deficits, gait ataxia and neuronal loss in the hippocampus and cerebellum in mice that are heterozygous for Pur-alpha. Neuroscience. 2016, 337:177-90. 10.1016\/j.neuroscience.2016.09.018","journal-title":"Neuroscience"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2004.08.007","article-title":"Pur alpha and Sp8 as opposing regulators of neural gata2 expression","volume":"275","author":"Penberthy WT","year":"2004","unstructured":"Penberthy WT, Zhao C, Zhang Y, et al.. Pur alpha and Sp8 as opposing regulators of neural gata2 expression. Dev Biol. 2004, 275:225-34. 10.1016\/j.ydbio.2004.08.007","journal-title":"Dev Biol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.295","article-title":"Pur-alpha functionally interacts with FUS carrying ALS-associated mutations","volume":"6","author":"Di Salvio M","year":"2015","unstructured":"Di Salvio M, Piccinni V, Gerbino V, et al.. Pur-alpha functionally interacts with FUS carrying ALS-associated mutations. Cell Death Dis. 2015, 6:e1943. 10.1038\/cddis.2015.295","journal-title":"Cell Death Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2007.07.020","article-title":"Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor\/ataxia syndrome","volume":"55","author":"Jin P","year":"2007","unstructured":"Jin P, Duan R, Qurashi A, et al.. Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor\/ataxia syndrome. Neuron. 2007, 55:556-64. 10.1016\/j.neuron.2007.07.020","journal-title":"Neuron"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1219643110","article-title":"Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration","volume":"110","author":"Xu Z","year":"2013","unstructured":"Xu Z, Poidevin M, Li X, et al.. Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc Natl Acad Sci U S A. 2013, 110:7778-83. 10.1073\/pnas.1219643110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.4161\/rna.19760","article-title":"Drosophila Pur-\u03b1 binds to trinucleotide-repeat containing cellular RNAs and translocates to the early oocyte","volume":"9","author":"Aumiller V","year":"2012","unstructured":"Aumiller V, Graebsch A, Kremmer E, Niessing D, F\u00f6rstemann K. Drosophila Pur-\u03b1 binds to trinucleotide-repeat containing cellular RNAs and translocates to the early oocyte. RNA Biol. 2012, 9:633-43. 10.4161\/rna.19760","journal-title":"RNA Biol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-025-01087-8","article-title":"Purine-rich element binding protein alpha: a DNA\/RNA binding protein with multiple roles in cancers","volume":"31","author":"Yu S","year":"2025","unstructured":"Yu S, Jiang C, Yang Y, Cheng F, Liu F, Liu C, Gong X. Purine-rich element binding protein alpha: a DNA\/RNA binding protein with multiple roles in cancers. Mol Med. 2025, 31:20. 10.1186\/s10020-025-01087-8","journal-title":"Mol Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1684\/epd.2021.1328","article-title":"Early-onset bradykinetic rigid syndrome and reflex seizures in a child with PURA syndrome","volume":"23","author":"Solazzi R","year":"2021","unstructured":"Solazzi R, Fiorini E, Parrini E, Guerrini R, Bernardina BD, Nardocci N, Cantalupo G. Early-onset bradykinetic rigid syndrome and reflex seizures in a child with PURA syndrome. Epileptic Disord. 2021, 23:745-8. 10.1684\/epd.2021.1328","journal-title":"Epileptic Disord"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.35439","article-title":"Clinical phenotype and candidate genes for the 5q31.3 microdeletion syndrome","volume":"158A","author":"Hosoki K","year":"2012","unstructured":"Hosoki K, Ohta T, Natsume J, et al.. Clinical phenotype and candidate genes for the 5q31.3 microdeletion syndrome. Am J Med Genet A. 2012, 158A:1891-6. 10.1002\/ajmg.a.35439","journal-title":"Am J Med Genet A"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-022-01217-4","article-title":"A 25 Mainland Chinese cohort of patients with PURA-related neurodevelopmental disorders: clinical delineation and genotype-phenotype correlations","volume":"31","author":"Dai W","year":"2023","unstructured":"Dai W, Sun Y, Fan Y, et al.. A 25 Mainland Chinese cohort of patients with PURA-related neurodevelopmental disorders: clinical delineation and genotype-phenotype correlations. Eur J Hum Genet. 2023, 31:112-21. 10.1038\/s41431-022-01217-4","journal-title":"Eur J Hum Genet"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1186\/s13039-015-0193-9","article-title":"Long-term follow-up of a patient with 5q31.3 microdeletion syndrome and the smallest de novo 5q31.2q31.3 deletion involving PURA","volume":"8","author":"Bonaglia MC","year":"2015","unstructured":"Bonaglia MC, Zanotta N, Giorda R, D'Angelo G, Zucca C. Long-term follow-up of a patient with 5q31.3 microdeletion syndrome and the smallest de novo 5q31.2q31.3 deletion involving PURA. Mol Cytogenet. 2015, 8:89. 10.1186\/s13039-015-0193-9","journal-title":"Mol Cytogenet"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a000356","article-title":"De novo mutations in PURA are associated with hypotonia and developmental delay","volume":"1","author":"Tanaka AJ","year":"2015","unstructured":"Tanaka AJ, Bai R, Cho MT, et al.. De novo mutations in PURA are associated with hypotonia and developmental delay. Cold Spring Harb Mol Case Stud. 2015, 1:a000356. 10.1101\/mcs.a000356","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032260","article-title":"Neuromuscular and neuromuscular junction manifestations of the PURA-NDD: a systematic review of the reported symptoms and potential treatment options","volume":"24","author":"Mroczek M","year":"2023","unstructured":"Mroczek M, Iyadurai S. Neuromuscular and neuromuscular junction manifestations of the PURA-NDD: a systematic review of the reported symptoms and potential treatment options. Int J Mol Sci. 2023, 24:2260. 10.3390\/ijms24032260","journal-title":"Int J Mol Sci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1097\/MOO.0000000000001015","article-title":"Management of paediatric sialorrhea","volume":"32","author":"Levi E","year":"2024","unstructured":"Levi E, Alexander W, Cooper MS. Management of paediatric sialorrhea. Curr Opin Otolaryngol Head Neck Surg. 2024, 32:444-52. 10.1097\/MOO.0000000000001015","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2022.07.022","article-title":"Genome sequencing is a sensitive first-line test to diagnose individuals with intellectual disability","volume":"24","author":"Lindstrand A","year":"2022","unstructured":"Lindstrand A, Ek M, Kvarnung M, et al.. Genome sequencing is a sensitive first-line test to diagnose individuals with intellectual disability. Genet Med. 2022, 24:2296-307. 10.1016\/j.gim.2022.07.022","journal-title":"Genet Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2024.1323014","article-title":"Case report: expanding the phenotypic spectrum of PURA syndrome in South America with the first presentation of concurrent vitiligo","volume":"12","author":"Mora-Martinez S","year":"2024","unstructured":"Mora-Martinez S, Casta\u00f1o-Giraldo N, Nati-Castillo HA, Barahona Machado L, Mora Arbel\u00e1ez T, Gordillo-Gonzalez G, Izquierdo-Condoy JS. Case report: expanding the phenotypic spectrum of PURA syndrome in South America with the first presentation of concurrent vitiligo. Front Pediatr. 2024, 12:1323014. 10.3389\/fped.2024.1323014","journal-title":"Front Pediatr"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2024.111983","article-title":"Fiberoptic endoscopic evaluation of swallowing (FEES) in pediatrics: a systematic review","volume":"181","author":"Pizzorni N","year":"2024","unstructured":"Pizzorni N, Rocca S, Eplite A, et al.. Fiberoptic endoscopic evaluation of swallowing (FEES) in pediatrics: a systematic review. Int J Pediatr Otorhinolaryngol. 2024, 181:111983. 10.1016\/j.ijporl.2024.111983","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/disabilities5010014","article-title":"Occupational and physical therapy interventions for young children with developmental central hypotonia: an overview of systematic reviews","volume":"5","author":"Paleg GS","year":"2025","unstructured":"Paleg GS, Robles \u00c1H, Govender P, Livingstone RW. Occupational and physical therapy interventions for young children with developmental central hypotonia: an overview of systematic reviews. Disabilities. 2025, 5:14. 10.3390\/disabilities5010014","journal-title":"Disabilities"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-016-0731-6","article-title":"Interventions to improve gross motor performance in children with neurodevelopmental disorders: a meta-analysis","volume":"16","author":"Lucas BR","year":"2016","unstructured":"Lucas BR, Elliott EJ, Coggan S, Pinto RZ, Jirikowic T, McCoy SW, Latimer J. Interventions to improve gross motor performance in children with neurodevelopmental disorders: a meta-analysis. BMC Pediatr. 2016, 16:193. 10.1186\/s12887-016-0731-6","journal-title":"BMC Pediatr"},{"key":"ref51","unstructured":"Anaesthesia recommendations for PURA Syndrome. (2019). Accessed. July, 2025: https:\/\/www.orphananesthesia.eu\/en\/rare-diseases\/published-guidelines\/pura-syndrome\/803-pura-syndrome-2\/file.html."},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.42.481","article-title":"Outcome of long-term vagus nerve stimulation for intractable epilepsy","volume":"42","author":"Kawai K","year":"2002","unstructured":"Kawai K, Shimizu H, Maehara T, Murakami H. Outcome of long-term vagus nerve stimulation for intractable epilepsy. Neurol Med Chir (Tokyo). 2002, 42:481-9; discussion 490. 10.2176\/nmc.42.481","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2010.12.003","article-title":"Long-term outcome of vagus nerve stimulation therapy after failed epilepsy surgery","volume":"20","author":"Vale FL","year":"2011","unstructured":"Vale FL, Ahmadian A, Youssef AS, Tatum WO, Benbadis SR. Long-term outcome of vagus nerve stimulation therapy after failed epilepsy surgery. Seizure. 2011, 20:244-8. 10.1016\/j.seizure.2010.12.003","journal-title":"Seizure"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2022.09.007","article-title":"PURA syndrome: neuromuscular junction manifestations with potential therapeutic implications","volume":"32","author":"Qashqari H","year":"2022","unstructured":"Qashqari H, McNiven V, Gonorazky H, et al.. PURA syndrome: neuromuscular junction manifestations with potential therapeutic implications. Neuromuscul Disord. 2022, 32:842-4. 10.1016\/j.nmd.2022.09.007","journal-title":"Neuromuscul Disord"},{"key":"ref55","article-title":"Sialorrhea: a management challenge","volume":"69","author":"Hockstein NG","year":"2004","unstructured":"Hockstein NG, Samadi DS, Gendron K, Handler SD. Sialorrhea: a management challenge. Am Fam Physician. 2004, 69:2628-34.","journal-title":"Am Fam Physician"},{"key":"ref56","article-title":"Salivary gland application of botulinum toxin for the treatment of sialorrhea","volume":"12","author":"Fuster Torres MA","year":"2007","unstructured":"Fuster Torres MA, Berini Ayt\u00e9s L, Gay Escoda C. Salivary gland application of botulinum toxin for the treatment of sialorrhea. Med Oral Patol Oral Cir Bucal. 2007, 12:E511-7.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2025.112305","article-title":"Adenotonsillectomy success for treating obstructive sleep apnea in children with Prader-Willi syndrome","volume":"192","author":"Rosen R","year":"2025","unstructured":"Rosen R, Hayden J, Saltagi A, Cleveland C, Otteson T, Baglam T. Adenotonsillectomy success for treating obstructive sleep apnea in children with Prader-Willi syndrome. Int J Pediatr Otorhinolaryngol. 2025, 192:112305. 10.1016\/j.ijporl.2025.112305","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17193111","article-title":"EZH2 dysregulation and its oncogenic role in human cancers","volume":"17","author":"Verma S","year":"2025","unstructured":"Verma S, Goyal N, Goyal S, Kaur P, Gupta S. EZH2 dysregulation and its oncogenic role in human cancers. Cancers (Basel). 2025, 17:3111. 10.3390\/cancers17193111","journal-title":"Cancers (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/473174-pura-related-neurodevelopmental-disorder-a-comprehensive-clinical-review-of-genetics-phenotype-and-emerging-therapeutic-strategies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:27:17Z","timestamp":1773422837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/473174-pura-related-neurodevelopmental-disorder-a-comprehensive-clinical-review-of-genetics-phenotype-and-emerging-therapeutic-strategies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":58,"URL":"https:\/\/doi.org\/10.7759\/cureus.105181","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,13]]}}}